...
首页> 外文期刊>Neoplasia: an international journal for oncology research >Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.
【24h】

Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.

机译:Hedgehog / Gli1通过卵巢肿瘤细胞转录调节<斜视> Fancd2 :其抑制诱导HR缺乏和协同致死性与PARP抑制。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Ovarian cancer (OC) is one of the most lethal type of cancer in women due to a lack of effective targeted therapies and high rates of treatment resistance and disease recurrence. Recently Poly (ADP-ribose) polymerase inhibitors (PARPi) have shown promise as chemotherapeutic agents; however, their efficacy is limited to a small fraction of patients with BRCA mutations. Here we show a novel function for the Hedgehog (Hh) transcription factor Glioma associated protein 1 (GLI1) in regulation of key Fanconi anemia (FA) gene, FANCD2 in OC cells. GLI1 inhibition in HR-proficient OC cells induces HR deficiency (BRCAness), replication stress and synergistic lethality when combined with PARP inhibition. Treatment of OC cells with combination of GLI1 and PARP inhibitors shows enhanced DNA damage, synergy in cytotoxicity, and strong in vivo anticancer responses.
机译:卵巢癌(OC)是由于缺乏有效的靶向疗法和高治疗抗性和疾病复发,是女性中最致命的癌症类型之一。 最近聚(ADP-核糖)聚合酶抑制剂(PARPI)已显示出作为化学治疗剂的承诺; 然而,它们的功效仅限于BRCA突变的一小部分患者。 在这里,我们展示了刺猬(HH)转录因子胶质瘤相关蛋白1(GLI1)的新功能,调节oc细胞中的FANCONI贫血(FA)基因,FANCD2。 GLI1在HR-Propiopion OC细胞中抑制诱导人力资源缺乏(BRCANESS),复制应力和协同致死致死致死致死。 用GLI1和PARP抑制剂组合治疗OC细胞显示出增强的DNA损伤,细胞毒性协同作用,体内抗癌反应强。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号